Activation or dampening of the NF-κB/IRF1 axis in dendritic cells has been demonstrated to affect the recruitment and activation of anti-tumor CD8+ T cells by influencing the IFN-γ response and the consequent recruitment and activation of anti-tumor CD8+ T cells in melanoma 24. The gene discussed is IRF1; the disease is neoplasm.